U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07689201) titled 'A Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib' on July 01.
Brief Summary: The goal of this study is to evaluate the study drug velzatinib (GSK6042981 / IDRX-42) to see whether velzatinib can shrink or control tumors and is safe and tolerated in Japan participants with gastrointestinal tumors (GIST) who progressed or were intolerant to standard therapies.
Study Start Date: Aug. 31
Study Type: INTERVENTIONAL
Condition:
Gastrointestinal Neoplasms
Intervention:
DRUG: Velzatinib
Velzatinib will be administered.
Recruitment Status: NOT_YET_RECRU...